QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, June 30, 2004, ():

This Article Abstract Full Text Submit an eLetter Services Email this article to a friend Alert me to new issues of the journal Citing Articles Citing Articles via Web of Science (21)

Sustained Extracellular Signal-Regulated Kinase 1/2 Phosphorylation in Neonate 6-Hydroxydopamine-Lesioned Rats after Repeated D₁-Dopamine Receptor Agonist Administration: Implications for NMDA Receptor Involvement
J. Neurosci. Papadeas et al. 24: 5863

Supplemental data

Supplemental Figure and Table

Files in this Data Supplement:

• Supplemental Fig. 1 - Figure A. Experimental paradigm. (1) SKF-38393 dosing regimen and time of sacrifice for neonate-lesioned and sham-lesioned rats used in the acute and chronic time course experiments. * Sham-lesioned rat group not represented at these time points. (2) Pre-treatment with SL327 prior to repeated doses of SKF-38393 to neonate-lesioned rats. SL = SL327; SKF = SKF-38393; Veh. = Vehicle (DMSO); (3) Pre-treatment with SCH-23390, ketanserin, MK-801, or CGS-19755 prior to repeated doses of SKF-38393 or saline. Antag. = antagonist = SCH-23390, ketanserin, MK-801, or CGS-19755.
• Supplemental Table 1

This Article Abstract Full Text Submit an eLetter Services Email this article to a friend Alert me to new issues of the journal Citing Articles Citing Articles via Web of Science (21)

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help